Recently, components of the NLRP3 inflammasome were found to be expressed in synovia of RA patients, and pentaxin 3 (PTX3), an essential component of innate immunity, has been suggested as a novel marker for the diagnosis of RA. Here, NLRP3 is linked to rheumatoid arthritis.